Artificial intelligence in healthcare is moving into a new phase. What was once dominated by research pilots and one-off experiments is now becoming a matter of ownership. Hospitals, medical device firms, insurers, and digital health startups are no longer just testing algorithms. They are building, buying, and maintaining AI products with real accountability. This shift has significant consequences for regulation and for patient outcomes, and it raises questions about how the healthcare system
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Headspace for Cigna Healthcare Enhances Mental Health Support
What You Should Know:
- Cigna Healthcare, the health benefits division of The Cigna Group, is significantly expanding its behavioral health offerings through an industry-first collaboration with Headspace. This partnership is designed to address the increasing rates of anxiety, stress, burnout, and sleep issues affecting the modern workforce.
- Millions of Cigna Healthcare customers will gain access to Headspace's digital mental health app, along with exclusive digital features such
Read More
Evidium Raises $22M to Scale Computational Medical Knowledge
What You Should Know:
- Evidium, an innovative healthcare artificial intelligence company, has announced the close of its Series A equity funding round co-led by Health2047, the venture studio of the American Medical Association (AMA), and WGG Partners with additional participation from Interwoven Ventures and Mindset Ventures.
- The investment will be used to accelerate product development, expand the company's clinical modeling capabilities, and scale its go-to-market operations to
Read More
Samsung Health Teams Up with iFIT for Premium Workout Integration
What You Should Know:
- Samsung has officially partnered with iFIT, a recognized leader in connected fitness and interactive content, to integrate a suite of premium workouts directly into the Samsung Health platform.
- The collaboration is designed to enhance the personalized fitness experience for millions of users, reinforcing Samsung’s commitment to preventive health.
Workout Variety and Free Monthly Content
Users can now access a wide range of expert-guided iFIT
Read More
Hepta Emerges from Stealth with $6.7M to Pioneer AI-Driven Chronic Disease Liquid Biopsy
What You Should Know:
- Hepta, a biotechnology company focused on diagnosing chronic disease, has emerged from stealth announcing $6.7M in seed funding co-led by Felicis Ventures and Illumina Ventures, with participation from SeaX Ventures, Alumni Ventures, and AME Cloud Ventures.
- The company's core technology utilizes transformer-based AI to read the cell-free DNA (cfDNA) epigenome, enabling the detection of organ-specific signals for chronic conditions. Built by former leaders from
Read More
Healthcare Consumer Experience 2025: Safety, AI, and Social Capital Redefine Trust
What You Should Know:
- Press Ganey, the leader in experience measurement, analytics, and advisory services for health systems and health plans, today released its extensive report, Healthcare consumer experience 2025.
- The report explores new data on how people make healthcare decisions in an era where patients are empowered consumers who expect clarity, convenience, and compassion in every interaction—digital or human. To keep pace, the industry must approach consumer
Read More
PocketHealth Launches Conductor Agentic AI System to Automate Every Non-Clinical Step of Care
What You Should Know:
- PocketHealth today announced the launch of Conductor, an agentic AI system built to automate every non-clinical step of care, from requisition intake and order creation to scheduling and appointment confirmations.
- The solution is directly aimed at helping healthcare systems across North America manage rising patient volumes, shrinking staff resources, and growing administrative costs.
I. Orchestrating Workflows to End the Administrative
Read More
Onchilles Pharma Raises $25M to Advance N17350, Pioneering Next-Gen Cytotoxic Cancer Therapy
What You Should Know:
- Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics announced the publication of foundational preclinical data in the peer-reviewed journal Cell Reports Medicine, the close of a $25M Series A1 financing round.
- In addition, the company appointed Dr. Thomas A. Buchholz as a clinical advisor. The funding brings the total raised in Series A financing to $40M.
Foundational Preclinical Data Validates Cancer-Selective
Read More
UHN and Helix Launch Canada’s Largest Population Genomics Initiative
What You Should Know:
- University Health Network's (UHN's) Princess Margaret Cancer Centre and Helix, a precision health organization, today announced a landmark partnership to launch one of the largest population genomics studies in Canada.
- The initiative, known as the OurGenes Study, aims to enroll up to 100,000 participants over five years, advancing precision medicine and the early detection of hereditary health risks.
Targeting Actionable Hereditary Health Risks
The
Read More
Trump Unveils Historic Drug Price Cuts: Ozempic and Wegovy Reduced to $350 via TrumpRx
What You Should Know:
- President Donald J. Trump announced the latest in a series of significant actions to lower prescription drug prices, unveiling agreements with pharmaceutical manufacturers Eli Lilly and Company and Novo Nordisk.
- The initiative delivers historic price reductions on some of the world’s most popular drugs, impacting millions of Americans struggling with chronic diseases, diabetes, heart disease, and obesity.
Price Reductions for Patients and
Read More
